Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has removed the previous version of the treatment for steroid-refractory acute graft-versus-host disease and replaced it with a new version dated August 13, 2025.SummaryDifference2%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
- Check51 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.